Alliance Jura-Hongrie Venture Capital Fund Management
Venture capitalBudapest · Series A–Series B · 1 people tracked
Team · 1 people
from the firm's websiteFrequently asked questions
- What stage does Alliance Jura-Hongrie Venture Capital Fund Management invest at?
- Alliance Jura-Hongrie Venture Capital Fund Management invests at the Series A, Series B stages.
- What is Alliance Jura-Hongrie Venture Capital Fund Management's typical check size?
- Alliance Jura-Hongrie Venture Capital Fund Management typically writes checks of $324K – $2.8M.
- What sectors does Alliance Jura-Hongrie Venture Capital Fund Management focus on?
- Alliance Jura-Hongrie Venture Capital Fund Management focuses on Biotech, Cleantech, Energy, Healthtech, Medical Devices, Sector Agnostic.
- Where is Alliance Jura-Hongrie Venture Capital Fund Management located?
- Alliance Jura-Hongrie Venture Capital Fund Management is headquartered in Budapest, HU.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.